A biopharmaceutical company focused on the acquisition and development of pharmaceutical drugs for treating autoimmune diseases, with its lead drug candidate hCDR1 in Phase II development for systemic lupus erythematosus and Sjogren's syndrome.
Ramat Gan, Israel~10 employeesFounded Jan 1993Website